Facebook
X
LinkedIn
Forward
15th Annual AKI Symposium
The symposium serves as a platform to spread kidney awareness and to educate and share resources with patients and the community.
Target Audience
The symposium is targeted for doctors, fellows, researchers, and professionals in the medical and research fi elds of critical care medicine, transplantation, nephrology, and the renal-electrolyte division
Learning Objectives
This symposium will promote the clinical knowledge related to diagnosis and personalized treatment of acute kidney injury (AKI). It will help to improve the care of critically ill patients who develop or are at risk for AKI. It will also promote communication and collaboration among experts and specialists treating and researching AKI. The understanding of AKI and the effective strategies for developing, implementing, and performing protocols for managing the condition will be enhanced.
Faculty Disclosure
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
David Huang, MD, MPH previously had grant/research support and is a consultant for Baxter.
Hernando Gomez, MD, MPH is a consultant for Trilinear Bioventures and Vantive and has grant/research support from BioMerieux and Baxter.
Raghavan Murugan, MD is CE Speakers’ Bureau for Baxter, Fresenius, and Vantive; is a consultant for Vantive; and has grant/research support from Vantive.
Alexander Zarbock, MD, PhD is CE Speakers’ Bureau for Baxter, Paion, BioMerieux; a consultant for BioMerieux, Baxter, Novartis, AM Pharma, Guard Therapeutics, Viatris, Alexion, Bayer; and has grant/research support from Baxter, BioMerieux, Alexion, Bayer.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.25 Attendance
We gratefully acknowledge support from Vantive US Healthcare LLC, BioPorto Diagnostics, MediBeacon Inc., Spectral Medical Inc. for their educational grants.